Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Response to concerns over primate brain studies
monkeys
Scientists raised concerns about the level of suffering involved in many neuroscience experiments.
Scientists say experiments are crucial for fighting human disease
 
Over 400 scientists have signed a letter claiming that research on primates is crucial for tackling neurodegenerative and other crippling diseases such as Parkinson's.

The letter, published by the Guardian, follows recent calls to end support for primate brain studies that involve fluid deprivation and movement restraint.

A group of 21 experts including Dr Jane Goodall and Sir David Attenborough last week wrote an open letter to UK and EU bodies that are responsible for licensing and funding brain experiments on monkeys.

They raised concerns about the level of suffering involved in many neuroscience experiments, particularly those depriving animals of water and restraining their movement, and said there are now sufficient human-based alternatives to 'call into serious question whether further research of this type is necessary.'

But hundreds of scientists have responded by saying research on non-human primates has played a key part in life-changing medical advances - including treatments for leprosy, HIV and Parkinson's - and their 'careful and considered use' is necessary for the ongoing fight against crippling human diseases.

'The biological similarities between humans and other primates mean that they are sometimes the only effective model for complex neurodegenerative diseases such as Parkinson's,' they wrote.

The group acknowledged that such research requires greater ethical justification due to the intelligence and sensitivity of non-human primates, and said the scientific community works together to minimise suffering 'wherever possible'.

They added: 'Stringent regulations across the developed world exist to ensure that primates are only used where there is no other available model – be that the use of a mouse or a non-animal alternative – and to protect the wellbeing of those animals still required. The use of primates is not undertaken lightly.'

However Dr Jane Goodall, who has studied chimpanzees for over 50 years, believes it is "morally wrong" to confine our primate relatives to laboratory cages and subject them to experiments that are often painful and distressing. In addition, she said fluid deprivation and movement restraint is "inhumane and extremely cruel".

 

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.